Perceptive Medical

Perceptive Medical is a private, clinical-stage medical device company pioneering automated vasopressor management. Its core product, the BaroHawk System, is a closed-loop controller that titrates drugs like norepinephrine to maintain a patient's target blood pressure, demonstrating reductions in hypotensive time by 90-95% in multiple randomized controlled trials. The company is positioned to address a significant unmet need in perioperative and critical care medicine by enhancing precision, improving patient safety, and increasing clinical efficiency. With strong academic validation and Breakthrough Device designation, Perceptive is advancing toward regulatory submission and commercialization.

Closed-loop automated control system for precise titration of vasopressor medications (e.g., norepinephrine) to maintain a clinician-set blood pressure target, integrating with standard hospital monitors and infusion pumps.

Direct competitors offering dedicated closed-loop vasopressor systems are limited, giving Perceptive a potential first-mover advantage. However, it competes indirectly with the entrenched standard of care (manual titration) and with companies developing advanced hemodynamic monitoring platforms (e.g., Edwards Lifesciences, Philips) that could eventually add automated drug delivery features. The competitive moat relies on clinical proof, algorithm sophistication, and intellectual property.